219 related articles for article (PubMed ID: 19443658)
1. Global reduction of the epigenetic H3K79 methylation mark and increased chromosomal instability in CALM-AF10-positive leukemias.
Lin YH; Kakadia PM; Chen Y; Li YQ; Deshpande AJ; Buske C; Zhang KL; Zhang Y; Xu GL; Bohlander SK
Blood; 2009 Jul; 114(3):651-8. PubMed ID: 19443658
[TBL] [Abstract][Full Text] [Related]
2. Leukaemic transformation by CALM-AF10 involves upregulation of Hoxa5 by hDOT1L.
Okada Y; Jiang Q; Lemieux M; Jeannotte L; Su L; Zhang Y
Nat Cell Biol; 2006 Sep; 8(9):1017-24. PubMed ID: 16921363
[TBL] [Abstract][Full Text] [Related]
3. hDOT1L links histone methylation to leukemogenesis.
Okada Y; Feng Q; Lin Y; Jiang Q; Li Y; Coffield VM; Su L; Xu G; Zhang Y
Cell; 2005 Apr; 121(2):167-78. PubMed ID: 15851025
[TBL] [Abstract][Full Text] [Related]
4. A CALM-derived nuclear export signal is essential for CALM-AF10-mediated leukemogenesis.
Conway AE; Scotland PB; Lavau CP; Wechsler DS
Blood; 2013 Jun; 121(23):4758-68. PubMed ID: 23487024
[TBL] [Abstract][Full Text] [Related]
5. The role of the PZP domain of AF10 in acute leukemia driven by AF10 translocations.
Klein BJ; Deshpande A; Cox KL; Xuan F; Zandian M; Barbosa K; Khanal S; Tong Q; Zhang Y; Zhang P; Sinha A; Bohlander SK; Shi X; Wen H; Poirier MG; Deshpande AJ; Kutateladze TG
Nat Commun; 2021 Jul; 12(1):4130. PubMed ID: 34226546
[TBL] [Abstract][Full Text] [Related]
6. Abrogation of MLL-AF10 and CALM-AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l.
Chen L; Deshpande AJ; Banka D; Bernt KM; Dias S; Buske C; Olhava EJ; Daigle SR; Richon VM; Pollock RM; Armstrong SA
Leukemia; 2013 Apr; 27(4):813-22. PubMed ID: 23138183
[TBL] [Abstract][Full Text] [Related]
7. A critical role for CRM1 in regulating HOXA gene transcription in CALM-AF10 leukemias.
Conway AE; Haldeman JM; Wechsler DS; Lavau CP
Leukemia; 2015 Feb; 29(2):423-32. PubMed ID: 25027513
[TBL] [Abstract][Full Text] [Related]
8. The PZP Domain of AF10 Senses Unmodified H3K27 to Regulate DOT1L-Mediated Methylation of H3K79.
Chen S; Yang Z; Wilkinson AW; Deshpande AJ; Sidoli S; Krajewski K; Strahl BD; Garcia BA; Armstrong SA; Patel DJ; Gozani O
Mol Cell; 2015 Oct; 60(2):319-27. PubMed ID: 26439302
[TBL] [Abstract][Full Text] [Related]
9. Clathrin assembly lymphoid myeloid leukemia-AF10-positive acute leukemias: a report of 2 cases with a review of the literature.
Huh JY; Chung S; Oh D; Kang MS; Eom HS; Cho EH; Han MH; Kong SY
Korean J Lab Med; 2010 Apr; 30(2):117-21. PubMed ID: 20445327
[TBL] [Abstract][Full Text] [Related]
10. The leukemogenic CALM/AF10 fusion protein alters the subcellular localization of the lymphoid regulator Ikaros.
Greif PA; Tizazu B; Krause A; Kremmer E; Bohlander SK
Oncogene; 2008 May; 27(20):2886-96. PubMed ID: 18037964
[TBL] [Abstract][Full Text] [Related]
11. AF10 regulates progressive H3K79 methylation and HOX gene expression in diverse AML subtypes.
Deshpande AJ; Deshpande A; Sinha AU; Chen L; Chang J; Cihan A; Fazio M; Chen CW; Zhu N; Koche R; Dzhekieva L; Ibáñez G; Dias S; Banka D; Krivtsov A; Luo M; Roeder RG; Bradner JE; Bernt KM; Armstrong SA
Cancer Cell; 2014 Dec; 26(6):896-908. PubMed ID: 25464900
[TBL] [Abstract][Full Text] [Related]
12. A higher-order configuration of the heterodimeric DOT1L-AF10 coiled-coil domains potentiates their leukemogenenic activity.
Song X; Yang L; Wang M; Gu Y; Ye B; Fan Z; Xu RM; Yang N
Proc Natl Acad Sci U S A; 2019 Oct; 116(40):19917-19923. PubMed ID: 31527241
[TBL] [Abstract][Full Text] [Related]
13. The role of CALM-AF10 gene fusion in acute leukemia.
Caudell D; Aplan PD
Leukemia; 2008 Apr; 22(4):678-85. PubMed ID: 18094714
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic strategies against hDOT1L as a potential drug target in MLL-rearranged leukemias.
Banday S; Farooq Z; Ganai SA; Altaf M
Clin Epigenetics; 2020 May; 12(1):73. PubMed ID: 32450905
[TBL] [Abstract][Full Text] [Related]
15. The leucine zipper motif of the Drosophila AF10 homologue can inhibit PRE-mediated repression: implications for leukemogenic activity of human MLL-AF10 fusions.
Perrin L; Bloyer S; Ferraz C; Agrawal N; Sinha P; Dura JM
Mol Cell Biol; 2003 Jan; 23(1):119-30. PubMed ID: 12482966
[TBL] [Abstract][Full Text] [Related]
16. H3K79 methylation profiles define murine and human MLL-AF4 leukemias.
Krivtsov AV; Feng Z; Lemieux ME; Faber J; Vempati S; Sinha AU; Xia X; Jesneck J; Bracken AP; Silverman LB; Kutok JL; Kung AL; Armstrong SA
Cancer Cell; 2008 Nov; 14(5):355-68. PubMed ID: 18977325
[TBL] [Abstract][Full Text] [Related]
17. Nuclear export signal within CALM is necessary for CALM-AF10-induced leukemia.
Suzuki M; Yamagata K; Shino M; Aikawa Y; Akashi K; Watanabe T; Kitabayashi I
Cancer Sci; 2014 Mar; 105(3):315-23. PubMed ID: 24397609
[TBL] [Abstract][Full Text] [Related]
18. MOZ/ENL complex is a recruiting factor of leukemic AF10 fusion proteins.
Komata Y; Kanai A; Maeda T; Inaba T; Yokoyama A
Nat Commun; 2023 Apr; 14(1):1979. PubMed ID: 37031220
[TBL] [Abstract][Full Text] [Related]
19. The clathrin-binding domain of CALM and the OM-LZ domain of AF10 are sufficient to induce acute myeloid leukemia in mice.
Deshpande AJ; Rouhi A; Lin Y; Stadler C; Greif PA; Arseni N; Opatz S; Quintanilla-Fend L; Holzmann K; Hiddemann W; Döhner K; Döhner H; Xu G; Armstrong SA; Bohlander SK; Buske C
Leukemia; 2011 Nov; 25(11):1718-27. PubMed ID: 21681188
[TBL] [Abstract][Full Text] [Related]
20. Targeting DOT1L action and interactions in leukemia: the role of DOT1L in transformation and development.
Barry ER; Corry GN; Rasmussen TP
Expert Opin Ther Targets; 2010 Apr; 14(4):405-18. PubMed ID: 20230194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
